BiotechTubeBiotechTube
Home/Pipeline/GRC 27864

GRC 27864

Atopic Dermatitis

Phase 2Active

Key Facts

Indication
Atopic Dermatitis
Phase
Phase 2
Status
Active
Company
Glenmark Pharmaceuticals

About Glenmark Pharmaceuticals

Glenmark Pharmaceuticals Limited is a research-driven global pharmaceutical company founded in 1977 and headquartered in Mumbai, India. The company operates across the pharmaceutical value chain with significant investments in R&D, particularly in respiratory diseases, dermatology, and oncology. Glenmark has successfully developed and commercialized innovative drugs while building a strong generic pharmaceuticals portfolio across key markets including the US, Europe, and emerging markets.

View full company profile

Therapeutic Areas

RespiratoryDermatologyOncologyCardiovascularCentral Nervous System

Other Atopic Dermatitis Drugs

DrugCompanyPhase
LebrikizumabEli LillyPhase 3
DupixentSanofiCommercial
ASP2408Astellas PharmaPhase 2
KW-6356Kyowa KirinPhase 2
KHK4083Kyowa KirinPhase 2
Opzelura (ruxolitinib cream)Ono PharmaceuticalApproved
ONO-7913Ono PharmaceuticalPhase 2
KT-474Kymera TherapeuticsPhase 2
ARQ-234Arcutis BiotherapeuticsPreclinical/Phase 1
STAR-0310BioCryst PharmaceuticalsPhase 1
RezpegaldesleukinNektar TherapeuticsPhase 2b
ZL-1503Zai LabPhase (Early Clinical)